IA
INBX icon

IFP Advisors’s Inhibrx INBX Stock Holding History

IFP Advisors’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4
Closed -$52 – 3873
2025
Q1 		$56 Hold
4
– – ﹤0.01% 3999
2024
Q4 		$62 Buy
+4
New +$61 ﹤0.01% 4190

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

IFP Advisors's INBX Position: Q2 2025 in Review

IFP Advisors sold out of Inhibrx (INBX) in Q2 2025, closing a stake of 4 shares — an estimated $52 sold.

IFP Advisors first reported a position in INBX in Q4 2024 and held it in 2 quarters. The position peaked at $62 in Q4 2024. 88 funds tracked by Wall St. Rank hold INBX as of Q2 2025.

  • IFP Advisors reported no remaining Inhibrx position as of Q2 2025 after selling out during the quarter.
  • IFP Advisors sold 4 Inhibrx shares in Q2 2025, an estimated $52.
  • IFP Advisors first reported a position in Inhibrx in Q4 2024 and held it in 2 quarters.
  • IFP Advisors's Inhibrx position peaked at $62 in Q4 2024.
  • 88 funds tracked by Wall St. Rank held Inhibrx as of Q2 2025.

Based on IFP Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.